Literature DB >> 21529607

Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin.

Joan Comenge1, Francisco M Romero, Carmen Sotelo, Fernando Domínguez, Victor Puntes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21529607     DOI: 10.1016/j.jconrel.2010.07.041

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  5 in total

1.  Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.

Authors:  Christopher G England; M Clarke Miller; Ashani Kuttan; John O Trent; Hermann B Frieboes
Journal:  Eur J Pharm Biopharm       Date:  2015-03-07       Impact factor: 5.571

Review 2.  Nanoparticle formulations of cisplatin for cancer therapy.

Authors:  Xiaopin Duan; Chunbai He; Stephen J Kron; Wenbin Lin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-02-05

3.  Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin.

Authors:  Joan Comenge; Carmen Sotelo; Francisco Romero; Oscar Gallego; Agustí Barnadas; Tomás García-Caballero Parada; Fernando Domínguez; Víctor F Puntes
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

4.  Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants.

Authors:  Silvia Gil; Eduardo Solano; Francesc Martínez-Trucharte; Jordi Martínez-Esaín; Ana J Pérez-Berná; José Javier Conesa; Christina Kamma-Lorger; Mercè Alsina; Manel Sabés
Journal:  PLoS One       Date:  2020-03-06       Impact factor: 3.240

5.  Assisted delivery of anti-tumour platinum drugs using DNA-coiling gold nanoparticles bearing lumophores and intercalators: towards a new generation of multimodal nanocarriers with enhanced action.

Authors:  Ana B Caballero; Lucia Cardo; Sunil Claire; James S Craig; Nikolas J Hodges; Anton Vladyka; Tim Albrecht; Luke A Rochford; Zoe Pikramenou; Michael J Hannon
Journal:  Chem Sci       Date:  2019-08-13       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.